Aligos Therapeutics, Inc. (ALGS)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
ALGS price, last 12 months
Key stats
- Previous close
- $1.30
- Open
- $1.28
- Day range
- $1.22 – $1.45
- 52-week range
- $1.18 – $13.69
- Volume
- 106K
- Avg volume (20 days)
- 78K
- Market cap
- $13.1M
Performance
Technicals and fundamentals
About Aligos Therapeutics, Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $13.1M